# Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium Injection
> **Food and Drug Administration** · Final rule. · Published 2006-07-12 · Effective 2006-07-12 · 71 FR 39204
## Document
- **Document number:** E6-10879
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 71 FR 39204
- **CFR reference:** 21 CFR 522
- **Publication date:** 2006-07-12
- **Effective date:** 2006-07-12
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA provides for a revised food safety warning on labeling for hyaluronate sodium injectable solution.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2006/07/12/E6-10879/implantation-or-injectable-dosage-form-new-animal-drugs-hyaluronate-sodium-injection)
---
*AI Analytics · CC0 1.0*